PIEZO1 and breast carcinoma: There have been several widely accepted methods to classify breast cancers into distinct subtypes [1–7], such as histopathological classification based on the morphological features, and analysis of the presence or absence of immunohistochemical (IHC) markers like ER, PR and HER2.